VIKING GLOBAL INVESTORS LPVIKING GLOBAL INVESTORS LP

Institutional investor · Portfolio as of Q1 2021

SEC EDGAR SourceSEC Filings

Top Holdings94 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

MICROSOFT CORP

8.5M$2B6.0%$183.20+21.71%
10 qtrssince 2018-Q4
Decreased
0

BRIDGEBIO PHARMA INC

26.6M$1.6B4.9%$26.97+128.40%
8 qtrssince 2019-Q2
Unchanged
0

FIDELITY NATIONAL INFO SERV

9.6M$1.3B4.0%$120.55+6.08%
6 qtrssince 2019-Q4
Decreased
0

T-MOBILE US INC

10.3M$1.3B3.8%$107.11+12.42%
5 qtrssince 2020-Q1
Increased
69

BANK OF AMERICA CORP

31.3M$1.2B3.6%$34.730.00%
1 qtr
New
88

Adaptive Biotechnologies Corp.

30M$1.2B3.6%$48.30-22.19%
8 qtrssince 2019-Q2
Unchanged
0

UNITEDHEALTH GROUP INC

3.1M$1.1B3.4%$320.56+7.80%
2 qtrssince 2020-Q4
Increased
65

ALPHABET INC-CL A

454,358$937.1M2.8%$82.01+23.84%
3 qtrssince 2020-Q3
Decreased
0

VISA INC-CLASS A SHARES

4M$855.1M2.5%$206.24-1.43%
10 qtrssince 2018-Q4
Decreased
0

PALO ALTO NETWORKS INC

2.5M$807.8M2.4%$57.74-8.21%
2 qtrssince 2020-Q4
Increased
70

GENERAL ELECTRIC CO

60.6M$796.3M2.4%

FORTIVE CORP - W/I

11.2M$790.5M2.4%$45.39+16.20%
7 qtrssince 2019-Q3
Increased
72

FLEETCOR TECHNOLOGIES INC

2.6M$707.1M2.1%
3 qtrssince 2020-Q3
Increased
63

CENTENE CORP

11M$701.5M2.1%$54.56+19.83%
10 qtrssince 2018-Q4
Decreased
0

META PLATFORMS INC-CLASS A

2.3M$691.7M2.1%$278.96+2.52%
2 qtrssince 2020-Q4
Increased
87

BOSTON SCIENTIFIC CORP

17.9M$691.7M2.1%$36.96+5.41%
10 qtrssince 2018-Q4
Decreased
0

API GROUP CORP

33.3M$689.3M2.1%$8.10+70.21%
4 qtrssince 2020-Q2
Unchanged
0

CHUBB LTD

4.2M$660.6M2.0%$122.34+20.13%
5 qtrssince 2020-Q1
Increased
70

ABCELLERA BIOLOGICS INC

19.1M$648.1M1.9%$41.10-72.94%
2 qtrssince 2020-Q4
Decreased
0

ZIMMER HOLDINGS INC

3.8M$611.7M1.8%$134.11+12.21%
3 qtrssince 2020-Q3
Decreased
0
$33.6B
AUM
94
Positions
Q1 2021
Filing
Rating · 2.0
Quarterly Portfolio Change
+11%Q4'19$21.4B-10%Q1'20$19.2B+20%Q2'20$23.1B+20%Q3'20$27.7B+31%Q4'20$36.4B-8%Q1'21$33.6B
Activity profile
$ moved · Q1'21
New25%Increased20%Decreased26%Exited29%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.2 quarters
<1Q27%1-4Q37%1-2Y19%2Y+17%

VIKING GLOBAL INVESTORS LP manages $33.6B across 94 positions as of Q1 2021. Top holdings: MSFT (6.0%), BBIO (4.9%), FIS (4.0%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 2/5.0.

Q1 2021 Summary

Active quarter - 28 new positions, 30 exits, 27 increased. Top move: BAC (NEW, conviction 88). Portfolio: $33.6B across 94 positions.

Top holdings by portfolio weight

Total AUM$34B
MSFT5.98%
BBIO4.88%
FIS4.02%
TMUS3.84%
BAC3.61%
ADPT3.60%
UNH3.41%
GOOGL2.79%
V2.55%
PANW2.41%
Other2.37%

Portfolio allocation by GICS sector

Sectors8
Healthcare32.80%
Technology18.59%
Financial Services16.27%
Communication Services11.06%
Industrials8.16%
Unknown6.81%
Consumer Cyclical6.28%
Consumer Defensive0.03%

Behavioral investing profile

Checking access…
Momentum Trader- primarily Healthcare, Technology, Financial Services
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track Record48
Conviction49
Concentration54
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
4Q
VVVISA INC-CLASS A SHARES
Q3 2025 Q2 2026+4.8M shares+$1.6B
3Q
MAAMAAMID-AMERICA APARTMENT COMM
Q4 2025 Q2 2026+2.4M shares+$331.1M
3Q
SESESEA LTD-ADR
Q4 2025 Q2 2026+2.6M shares+$147,561
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used